491 related articles for article (PubMed ID: 15869477)
1. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine.
Semba J; Akanuma N; Wakuta M; Tanaka N; Suhara T
Brain Res Mol Brain Res; 2004 Apr; 124(1):88-95. PubMed ID: 15093689
[TBL] [Abstract][Full Text] [Related]
3. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.
Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU
Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076
[TBL] [Abstract][Full Text] [Related]
4. Glial cell line-derived neurotrophic factor receptor GFRalpha1 is expressed in the rat striatum during postnatal development.
Cho J; Yarygina O; Oo TF; Kholodilov NG; Burke RE
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):96-104. PubMed ID: 15306125
[TBL] [Abstract][Full Text] [Related]
5. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
6. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.
Smith AD; Antion M; Zigmond MJ; Austin MC
Brain Res Mol Brain Res; 2003 Oct; 117(2):129-38. PubMed ID: 14559146
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.
Kozlowski DA; Miljan EA; Bremer EG; Harrod CG; Gerin C; Connor B; George D; Larson B; Bohn MC
Brain Res; 2004 Aug; 1016(2):170-81. PubMed ID: 15246853
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
9. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
10. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
11. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
12. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
Lei Z; Jiang Y; Li T; Zhu J; Zeng S
J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
14. The role of Ret receptor tyrosine kinase in dopaminergic neuron development.
Li L; Su Y; Zhao C; Zhao H; Liu G; Wang J; Xu Q
Neuroscience; 2006 Oct; 142(2):391-400. PubMed ID: 16879925
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
16. GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection.
Lindqvist N; Peinado-Ramónn P; Vidal-Sanz M; Hallböök F
Exp Neurol; 2004 Jun; 187(2):487-99. PubMed ID: 15144875
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn.
Jongen JL; Haasdijk ED; Sabel-Goedknegt H; van der Burg J; Vecht ChJ; Holstege JC
Exp Neurol; 2005 Jul; 194(1):255-66. PubMed ID: 15899262
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]